The Traderszone Network

Published in TZ Latest News 16 March, 2017 by The TZ Newswire Staff

3 IBM Moonshots Shareholders Should Know About

Who knew that a company as big and well-known as IBM (NYSE: IBM) could become a battleground stock? In the span of a day, two sell-side analysts gave two starkly different takes on the company. Jefferies analyst James Kisner reiterated his underperform rating on the company, with a price target of $125, while Drexel Hamilton analyst Brian White raised his target to an outperform and a whopping $215. The stock currently trades near the midpoint of the two, at $180 per share and 14.5 times earnings.

read more